121 related articles for article (PubMed ID: 1677889)
1. [The pharmacologist facing the neuroleptics].
Costentin J
Encephale; 1991 Jun; 17 Spec No 2():153-7. PubMed ID: 1677889
[No Abstract] [Full Text] [Related]
2. Pharmacology of neuroleptics in use in the United States.
Richelson E
J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):8-14. PubMed ID: 2862140
[TBL] [Abstract][Full Text] [Related]
3. Receptor pharmacology of neuroleptics.
Pearson RM
Hosp Med; 2000 Sep; 61(9):647-9. PubMed ID: 11048607
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology and mechanism of action of existing and new neuroleptics.
Niemegeers CJ
Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):26-36. PubMed ID: 1981439
[No Abstract] [Full Text] [Related]
5. [Are the antipsychotic and side-effects of neuroleptics imperfectly known?].
Schulz P
Biomed Pharmacother; 1987; 41(1):31-3. PubMed ID: 2886159
[TBL] [Abstract][Full Text] [Related]
6. [New anti-psychotic drugs].
Lôo H; Brochier T; Meidinger A
Presse Med; 1991 May; 20(19):889-90. PubMed ID: 1676163
[No Abstract] [Full Text] [Related]
7. [Neuroleptics in geriatrics. Pharmacological criteria for a responsible choice and a correct use].
van Wielink PS
Tijdschr Gerontol Geriatr; 1984 Apr; 15(2):73-80. PubMed ID: 6144201
[TBL] [Abstract][Full Text] [Related]
8. Clinical evidence for multiple dopamine receptors in man.
Meltzer HY
Commun Psychopharmacol; 1979; 3(6):457-70. PubMed ID: 44694
[No Abstract] [Full Text] [Related]
9. 5-HT6 receptor ligands and their antipsychotic potential.
Arnt J; Olsen CK
Int Rev Neurobiol; 2011; 96():141-61. PubMed ID: 21329787
[No Abstract] [Full Text] [Related]
10. [Psychopharmacology in a genomic perspective].
Werge T; Kessing LV
Ugeskr Laeger; 2005 May; 167(20):2194-6. PubMed ID: 15987083
[No Abstract] [Full Text] [Related]
11. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
Arushanian EB
Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
[No Abstract] [Full Text] [Related]
12. Pharmacology of antipsychotic drugs.
Borison RL
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):25-8. PubMed ID: 2858475
[TBL] [Abstract][Full Text] [Related]
13. [Current concepts of the effects of neuroleptics].
Kostowski W; Płaźnik A
Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
[No Abstract] [Full Text] [Related]
14. [Significance of brain nondopaminergic mechanisms for the specific action and side effects of neuroleptics].
Arushanian EB
Farmakol Toksikol; 1983; 46(1):99-107. PubMed ID: 6130975
[No Abstract] [Full Text] [Related]
15. Receptor pharmacology of neuroleptics: relation to clinical effects.
Richelson E
J Clin Psychiatry; 1999; 60 Suppl 10():5-14. PubMed ID: 10340682
[TBL] [Abstract][Full Text] [Related]
16. Neuropharmacology of zotepine, an antimanic drug: a potent blocker of D2 and 5-HT2 receptors of human brain.
Kanba S; Yagi G; Oguchi E; Nakaki T; Kato R; Richelson E
Jpn J Psychiatry Neurol; 1991 Mar; 45(1):133-4. PubMed ID: 1684393
[No Abstract] [Full Text] [Related]
17. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
Kudo T
Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953
[No Abstract] [Full Text] [Related]
18. Neuronal links in the CNS: focus on dopaminergic and serotonergic regulation of striatal cholinergic neurons.
Garattini S; Consolo S; Ladinski H
Pol J Pharmacol Pharm; 1980; 32(2):155-64. PubMed ID: 7454621
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects.
Strange PG
Pharmacol Rev; 2001 Mar; 53(1):119-33. PubMed ID: 11171942
[TBL] [Abstract][Full Text] [Related]
20. Neurochemistry and child psychiatry.
Cohen DJ; Young JG
J Am Acad Child Psychiatry; 1977; 16(3):353-411. PubMed ID: 18499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
